Applied Materials Introduces New Sym3® Etch System for Advanced Memory and Logic Chips
Sym3® Y tailored to critical conductor etch applications in 3D NAND, DRAM and foundry-logic nodesNewest offering broadens adoption of the […]
PFSweb Reports Record Second Quarter 2020 Results
ALLEN, Texas, Aug. 07, 2020 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, is reporting results […]
Sprott Announces 2020 Second Quarter Results
TORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results […]
XORTX Appoints Dr. David Sans in New York as Director Corporate Development
CALGARY, Alberta, Aug. 07, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a […]
Greenlane Announces Second Quarter 2020 Financial Results
BOCA RATON, Fla., Aug. 07, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), one of […]
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
Clinical proof of principle established with RP1 in combination with Opdivo® for the treatment of immune-responsive tumors supporting registration directed […]
Virtu Announces Second Quarter 2020 Results
NEW YORK, Aug. 07, 2020 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NASDAQ: VIRT), a leading provider of financial services and […]
Altimmune Completes Enrollment in Phase 1b Clinical Trial of NasoShield™, a Single Dose Intranasal Anthrax Vaccine Candidate
GAITHERSBURG, Md., Aug. 07, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it […]
Aclaris Therapeutics Reports Second Quarter 2020 Financial Results and Provides R&D and Business Highlights
WAYNE, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing […]
Arvinas to Present at the 2020 Wedbush PacGrow Virtual Healthcare Conference
NEW HAVEN, Conn., Aug. 07, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]
